osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh
Clicks: 256
ID: 134768
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
256 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #8 of 17 articles by views in pediatric urology case reports
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
В статье обсуждается взаимное влияние сердечно-сосудистой патологии и заболеваний, сопровождающихся бронхообструктивным синдромом. Особое внимание уделено выбору антигипертензивного препарата у пациентов с хронической обструктивной болезнью легких с учетом отсутствия четких рекомендаций по данному вопросу. Вновь акцентирована возможность применения кардиоселективных b-адреноблокаторов у больных данной группы без негативного влияния на показатели функции внешнего дыхания.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (2 words).
Try re-searching for a better abstract.
| Reference Key |
napalkov2013osobennosti
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Dmitriy Aleksandrovich Napalkov;Aleksandr Sergeevich Panferov |
| Journal | pediatric urology case reports |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.